Skip to main content
S&P 5007,688.62+1.58%DOW53,356.12+3.03%NASDAQ25,736.51+1.44%BTC$80,787.00+5.07%ETH$2,431.65+7.47%GOLD$4,134.30+1.51%OIL$87.17-1.08%
Smart Investors Daily
SID Premium
GN

NASDAQ · GNTA

Genenta Science S.p.A.

Healthcare · Biotechnology

$0.99

Up+$0.17 (+20.62%)

Updated Nov 5, 2026, 2:50 AM

SID Score

5.4/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
31.78M
P/E ratio
-3.05
Dividend yield
0.00%
52-week range
$0.55 – $2.58
Volume
337.5K
Avg. volume
666.12K

Price performance · GNTA

GNTA price history

1M range · 20 trading sessions · Daily adjusted prices

Prices through Nov 3, 2026

GNTA closed at $0.99 after 20 trading sessions, up 30.46% for the selected period.

Last close
$0.99
Period change
+30.46%
Period low
$0.61
Period high
$0.99
Daily close
View OHLC price history
GNTA OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 3, 2026$0.8359$0.99$0.8189$0.985337.5K
Nov 2, 2026$0.6611$0.87$0.6611$0.81661.58M
Oct 30, 2026$0.62$0.6365$0.60$0.618367.2K
Oct 29, 2026$0.5997$0.62$0.5801$0.62153.2K
Oct 28, 2026$0.582$0.63$0.582$0.60542.19K
Oct 27, 2026$0.633$0.6369$0.591$0.618218.9K
Oct 26, 2026$0.615$0.634$0.5955$0.624428.86K
Oct 23, 2026$0.6399$0.6399$0.63$0.630113.37K
Oct 22, 2026$0.661$0.661$0.6301$0.630136.97K
Oct 21, 2026$0.61$0.6598$0.61$0.6436.76K
Oct 20, 2026$0.6998$0.6998$0.61$0.61524.86K
Oct 19, 2026$0.65$0.67$0.61$0.6588129.39K
Oct 16, 2026$0.66$0.6787$0.65$0.67539.5K
Oct 15, 2026$0.71$0.71$0.6606$0.669416.2K
Oct 14, 2026$0.705$0.7461$0.6602$0.660288.48K
Oct 13, 2026$0.7457$0.7515$0.72$0.72234.28K
Oct 12, 2026$0.7474$0.7629$0.74$0.759926.46K
Oct 9, 2026$0.727$0.7985$0.727$0.785262.97K
Oct 8, 2026$0.7501$0.7771$0.7101$0.710153.73K
Oct 7, 2026$0.776$0.80$0.75$0.75523.37K

Latest GNTA news

The latest Smart Investors Daily articles mentioning GNTA.

Stock researchCompany · Overview

GNTA research

Overview

Company profile and research snapshot.

Company profile

Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
GNTA recent ratings
DateFirmRatingTarget
Oct 2, 2024HC Wainwright & Co.Buy—
May 13, 2024HC Wainwright & Co.Buy—
Feb 8, 2023HC Wainwright & Co.Buy—
Jan 5, 2023EF HuttonBuy—
Jul 25, 2022HC Wainwright & Co.Buy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 21, 2026

Genenta Science Announces Receipt of Nasdaq Minimum Bid Price Deficiency Notification

MILAN, Italy, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Genenta Science S.p.A. (Nasdaq: GNTA) (the “Company”) today announced that on October 16, 2026, it received a notification letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company is not in compliance with the minimum bid price requirement of $1.00 per share under Nasdaq Listing Rule 5550(a)(2). The notification was issued because the closing bid price of the Company’s American Deposita

Yahoo · Sep 15, 2026

Sòphia High Tech Flight Hardware on Board VEGA-C VV30 as the European Launcher Carries Sentinel-3C and FLEX into Orbit

The Spring Assembly manufactured by Sòphia HT, a strategic Genenta investment, supports the separation of the launcher’s second and third stages Sòphia HT has been in serial production of the component since 2018 MILAN, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Genenta Science S.p.A. (Nasdaq: GNTA), evolving into Saentra Forge1, a strategic industrial consolidator focused on aerospace, defense, national security and biotechnology, today announced that Sòphia High Tech S.r.l. (Sòphia HT), the Italian ae

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By